The pulmonary route has long been used for drug administration for both local and systemic
treatment. It possesses several advantages, which can be categorized into physiological, ie …

Local administration of therapeutics by inhalation for treatment of lung diseases has the
ability to deliver drugs, nucleic acids and peptides specifically to the site of their action and …

Lung cancer is an umbrella term for a subset of heterogeneous diseases that are collectively
responsible for the most cancer-related deaths worldwide. Despite the tremendous progress …

Lung cancer (LC) is one of the leading causes of mortality accounting for almost 25% of
cancer deaths throughout the world. The shortfall of affordable and effective first-line …

Lung cancer is the second most prevalent and the deadliest among all cancer types.
Chemotherapy is recommended for lung cancers to control tumor growth and to prolong …

Idiopathic pulmonary fibrosis (IPF) is a debilitating and fatal condition that causes severe
scarring of the lungs. While the pathogenesis of IPF continues to be extensively studied and …

Administration of drug molecules by inhalation route for treatment of respiratory diseases
has the ability to deliver drugs, hormones, nucleic acids, steroids, proteins, and peptides …

Lung cancer is a complex thoracic malignancy developing consequential to aberrations in a
myriad of molecular and biomolecular signaling pathways. It is one of the most lethal forms …

Chronic obstructive pulmonary disease (COPD) is the most prevalent obstructive lung
disease worldwide characterized by decline in lung function. It is associated with airway …

Lung cancer is among the most prevalent and leading causes of death worldwide. The
major reason for high mortality is the late diagnosis of the disease, and in most cases, lung …